Manuel S. Rodríguez

Dr. Manuel S. Rodríguez

Laboratoire de Chimie de Coordination LCC-UPR 8241-IPBS-CNRS 205 Route de Narbonne, 31400 Toulouse, France
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1998 in Molecular Cell
Verified
Journal Article
Closed access
JDJoana Desterro
Joana Desterro
Manuel S. RodríguezManuel S. Rodríguez
Manuel S. Rodríguez
RHRonald T Hay
Ronald T Hay

1 July 2019 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
MMMichael Mattern
Michael Mattern
JSJames Sutherland
James Sutherland
KKKarteek Kadimisetty
Karteek Kadimisetty
RBRosa Barrio
Rosa Barrio
Manuel S. RodríguezManuel S. Rodríguez
Manuel S. Rodríguez

18 November 2016 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RMRakel López de Maturana
Rakel López de Maturana
VLValérie Lang
Valérie Lang
AZAmaia Zubiarrain
Amaia Zubiarrain
ASAmaya Sousa
Amaya Sousa
NVNerea Vázquez
Nerea Vázquez
RSRosario Sánchez-Pernaute
Rosario Sánchez-Pernaute
Mutations in leucine-rich repeat kinase 2 (LRRK2) contribute to both familial and idiopathic forms of Parkinson’s disease (PD). Neuroinflammation is a key event in neurodegeneration and aging, and there is mounting evidence of LRRK2 involvement in inflammatory pathways. In a previous study, we described an alteration of the inflammatory response in dermal fibroblasts from PD patients expressing the G2019S and R1441G mutations in LRRK2. Taking advantage of cellular reprogramming, we generated induced pluripotent stem cell (iPSC) lines and neurons thereafter, harboring LRRK2G2019S and LRRK2R1441G mutations. We used gene silencing and functional reporter assays to characterize the effect of the mutations. We examined the temporal profile of TNFα-induced changes in proteins of the NF-κB pathway and optimized western blot analysis to capture α-synuclein dynamics. The effects of the mutations and interventions were analyzed by two-way ANOVA tests with respect to corresponding controls. LRRK2 silencing decreased α-synuclein protein levels in mutated neurons and modified NF-κB transcriptional targets, such as PTGS2 (COX-2) and TNFAIP3 (A20). We next tested whether NF-κB and α-synuclein pathways converged and found that TNFα modulated α-synuclein levels, although we could not detect an effect of LRRK2 mutations, partly because of the individual variability. Nevertheless, we confirmed NF-κB dysregulation in mutated neurons, as shown by a protracted recovery of IκBα and a clear impairment in p65 nuclear translocation in the LRRK2 mutants. Altogether, our results show that LRRK2 mutations affect α-synuclein regulation and impair NF-κB canonical signaling in iPSC-derived neurons. TNFα modulated α-synuclein proteostasis but was not modified by the LRRK2 mutations in this paradigm. These results strengthen the link between LRRK2 and the innate immunity system underscoring the involvement of inflammatory pathways in the neurodegenerative process in PD.

4 November 2015 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
EUEnric Ureña
Enric Ureña
LPLucia Pirone
Lucia Pirone
SCSilvia Chafino
Silvia Chafino
CPCoralia Pérez
Coralia Pérez
JSJames Sutherland
James Sutherland
DMDavid Martín
David Martín
SUMOylation, the covalent binding of Small Ubiquitin-like Modifier (SUMO) to target proteins, is a posttranslational modification that regulates critical cellular processes in eukaryotes. In insects, SUMOylation has been studied in holometabolous species, particularly in the dipteran Drosophila melanogaster, which contains a single SUMO gene (smt3). This has led to the assumption that insects contain a single SUMO gene. However, the analysis of insect genomes shows that basal insects contain two SUMO genes, orthologous to vertebrate SUMO1 and SUMO2/3. Our phylogenetical analysis reveals that the SUMO gene has been duplicated giving rise to SUMO1 and SUMO2/3 families early in Metazoan evolution, and that later in insect evolution the SUMO1 gene has been lost after the Hymenoptera divergence. To explore the consequences of this loss, we have examined the characteristics and different biological functions of the two SUMO genes (SUMO1 and SUMO3) in the hemimetabolous cockroach Blattella germanica and compared them with those of Drosophila Smt3. Here, we show that the metamorphic role of the SUMO genes is evolutionary conserved in insects, although there has been a regulatory switch from SUMO1 in basal insects to SUMO3 in more derived ones. We also show that, unlike vertebrates, insect SUMO3 proteins cannot form polySUMO chains due to the loss of critical lysine residues within the N-terminal part of the protein. Furthermore, the formation of polySUMO chains by expression of ectopic human SUMO3 has a deleterious effect in Drosophila. These findings contribute to the understanding of the functional consequences of the evolution of SUMO genes.

1 April 2016 in Journal of Proteomics
Verified
Journal Article
Closed access
LMLydia Mata-Cantero
Lydia Mata-Cantero
MAMikel Azkargorta
Mikel Azkargorta
FAFabienne Aillet
Fabienne Aillet
WXWendy Xolalpa
Wendy Xolalpa
MLMaria J. LaFuente
Maria J. LaFuente
Manuel S. RodríguezManuel S. Rodríguez
Manuel S. Rodríguez

18 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
GQGrégoire Quinet
Grégoire Quinet
MGMaria Gonzalez-Santamarta
Maria Gonzalez-Santamarta
CLClara Louche
Clara Louche
Manuel S. RodríguezManuel S. Rodríguez
Manuel S. Rodríguez
Protein degradation is tightly regulated inside cells because of its utmost importance for protein homeostasis (proteostasis). The two major intracellular proteolytic pathways are the ubiquitin-proteasome and the autophagy-lysosome systems which ensure the fate of proteins when modified by various members of the ubiquitin family. These pathways are tightly interconnected by receptors and cofactors that recognize distinct chain architectures to connect with either the proteasome or autophagy under distinct physiologic and pathologic situations. The degradation of proteasome by autophagy, known as proteaphagy, plays an important role in this crosstalk since it favours the activity of autophagy in the absence of fully active proteasomes. Recently described in several biological models, proteaphagy appears to help the cell to survive when proteostasis is broken by the absence of nutrients or the excess of proteins accumulated under various stress conditions. Emerging evidence indicates that proteaphagy could be permanently activated in some types of cancer or when chemoresistance is observed in patients.